In NAFLD subjects, sclerostin was closely and negatively correlated with TG, BW and BW-related indicators, while in controls, sclerostin was positively and significantly correlated with insulin and HOMA-IR, and negatively correlated with HDL-C. The gene discussed is SOST; the disease is metabolic dysfunction-associated steatotic liver disease.